Schechter Investment Advisors, LLC Exelixis, Inc. Transaction History
Schechter Investment Advisors, LLC
- $997 Million
- Q3 2024
A detailed history of Schechter Investment Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 12,889 shares of EXEL stock, worth $469,932. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,889
Previous 12,499
3.12%
Holding current value
$469,932
Previous $280,000
19.29%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
503Shares Held
244MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.22 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$1.07 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$926 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$560 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$417 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...